UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000059197
Receipt number R000067706
Scientific Title Examination of the effect of test food intake on the promotion of alcohol metabolism after drinking in adults
Date of disclosure of the study information 2025/09/26
Last modified on 2025/09/26 09:40:29

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Examination of the effect of test food intake on the promotion of alcohol metabolism after drinking in adults

Acronym

Examination of the effect of test food intake on the promotion of alcohol metabolism after drinking in adults

Scientific Title

Examination of the effect of test food intake on the promotion of alcohol metabolism after drinking in adults

Scientific Title:Acronym

Examination of the effect of test food intake on the promotion of alcohol metabolism after drinking in adults

Region

Japan


Condition

Condition

Healthy Adults

Classification by specialty

Not applicable

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the effects of a food containing acetic acid bacteria extract powder on alcohol metabolism after drinking in adults aged 20 years or older.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Questionnaire on Performance

Key secondary outcomes

Breath ethanol concentration measurement, Performance testing, OSA Sleep Assessment Questionnaire MA version (OSA-MA)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Take three test meals before drinking alcohol

Interventions/Control_2

Take three placebo tablets before drinking alcohol

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >

Gender

Male and Female

Key inclusion criteria

1. Persons who received a sufficient explanation of the purpose and contents of the research, have the capacity to consent, applied with free will with sufficient understanding, and agreed to participate
2. Persons who regularly drink alcohol and can drink 180 mL of sake (15% alcohol) without any problems, but are aware of getting drunk.
3. Persons who are Japanese citizens, aged 20 or older and under 65 at the time of consent

Key exclusion criteria

1. Persons who have chronic diseases and are receiving drug treatment, or have a history of serious illness
2. Persons who have been diagnosed with diabetes
3. Persons who usually take medicine, specified health food, foods with function claims, and foods with nutrient function claims that may have effects on alcohol metabolism or sleep quality
4. Persons who are at risk of developing allergies related to the test foods
5. Persons who drink a large amount of alcohol (60 g or more of alcohol per day: approximately 1500 mL of beer, 540 mL of wine, 3 cups of sake, or 180 mL of double-sized whiskey)
6. Persons who regularly consume large amounts of the test food
7. Persons who are judged unsuitable as research subjects based on their responses to a background survey
8. Persons who have participated in other research during one month prior to the start of this research, or plan to participate in other research after consenting to this research.
9. Persons who are breastfeeding, pregnant, or have plans to become pregnant during the study period
10. Persons who are judged to be ineligible by the principal investigator

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Takumi
Middle name
Last name Tochio

Organization

BIOSIS Lab. Co., Ltd.

Division name

CEO

Zip code

470-1101

Address

Room 506, Building No. 11, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, JAPAN

TEL

090-6904-6772

Email

takumitochiobiz@gmail.com


Public contact

Name of contact person

1st name Takumi
Middle name
Last name Tochio

Organization

BIOSIS Lab. Co., Ltd.

Division name

CEO

Zip code

470-1101

Address

Room 506, Building No. 11, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, JAPAN

TEL

090-6904-6772

Homepage URL


Email

takumitochiobiz@gmail.com


Sponsor or person

Institute

BIOSIS Lab. Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

SYNKEN Co., Ltd

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Ethics Committee of Healthcare Systems Co., Ltd.

Address

1-14-18, Shirakane, Showa-ku, Nagoya, Aichi, JAPAN

Tel

03-6809-2722

Email

soumu@hc-sys.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 09 Month 26 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 09 Month 11 Day

Date of IRB

2025 Year 09 Month 11 Day

Anticipated trial start date

2025 Year 10 Month 02 Day

Last follow-up date

2025 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 09 Month 26 Day

Last modified on

2025 Year 09 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067706